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                                                    Abstract 
 
Introduction: Cancer patients have to face and dial with  many questions and factors such 
as receiving bad news of repeated threats to their own life, suffering from pain, luck of 
support and loosing meaning of life. Patients also face new social roles, lifestyle and medical 
treatment expense. All of these factors cause anxiety, fear of death, loss of confidence and 
some of them may have major depressive disorder.  According to Yu et al. (2012) the study 
of cancer co-morbidity with depression has been challenged because depressive symptoms 
range from reactions to mood disorder, through intense anxiety to major depressive disorder. 
Depressive disorder and suicidality and co-morbid with cancer is underestimated and under-
treated. This was main motivation to try with this research to answer on some questions 
which in our opinion will help physicians to pay more attention to this condition.   
 Objectives: The first aim of this study was to asses prevalence of depression and 
suicidality among patients with diagnosed cancer in maxillofacial region. Additionally, 
the second aim was to check correlation between pain and depressed cancer 
patients.  
Material and Methods: In the frame of the UGD supported project, the data were 
collected from Department of maxillofacial surgery, Clinical Hospital, Stip, 
Macedonia, during the period 2014-2016. Patients with diagnosed cancer in 
maxillofacial region participated in this study. The final survey sample consists of 115 
patients (64% female and 36% male) aged 19-70 years. In order to asses 
depression and suicidality we applied: Patient Health Questionnaire-9 (PHQ-9) and 
M.I.N.I. structured clinical interview (module for suicidal risk). We assessed severity 
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of pain by using a Visual Analog Scale (VAS). Written informed consent was 
obtained by all participants. 
Results: Prevalence of depression  
Of 115 study patients, 52 patients (45.52%) with PHQ-9 scores=10 or more were classified 
in the depressive group. Among these, twenty seven patients  (51.92 %) experienced mild 
depression,thirteen (25%) had moderate depression and twelve (23.07%) were in severe 
depression.Sensitivity and specificity of diagnosis being correctly were 25.0% and 9.2% 
respectively.  
Pain and depression  
Mann-Whitney U testing showed that cancer patients with depression  experienced 
significantly more pain than cancer patients without depression (p<0.001). If patients were 
classified according to pain level, we found that ten (19.23%) and twelve (23.08%) 
depressed cancer patients had moderate and severe pain level respectively.  
Additionaly, Mann-Whitney U testing showed that cancer patients with high depressive and 
pain score significantly have higher risk of suicidality than cancer patients without those 
factors (p< 0.001 and p< 0.001, respectively). Cancer patients with depression and pain 
were 1.4 (95% CI interval =1.06 -1.52) and 1.2 (95% CI interval=1.09-1.25) times more 
prone to have suicidal risk, respectively.    
 Conclusion: We can conclude that depressive disorder is the one of the most 
common problem in cancer patients and it deserve additional attention. The 
prevalence of 45.22 % is fit with the higher range of some findings of previous 
studies (3%-58%). The prevalence of suicidality (32.69%) also show us that the 
mechanism of the association between cancer, depression, suicidality and pain 
should be approached as holistic (biopsychosocial model), not as a single disorder. 
Due to the limitation of this study, more prospective screening studies are needed in 
future. There is a need of multidisciplinary work and teams between maxillofacial 
surgeons, clinical psychologist, psychiatrist and oncologist. 
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